NCT04233892 - Clinical Study of in Situ Regeneration of Endometrium | Biotech Hunter

Enrollment

345

Participants

Timeline

Start Date

April 29, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2024

Conditions

Infertility, Female, of Uterine OriginEndometrial Fibrosis

Interventions

DRUG

CBD-bFGF

CBD-bFGF will be injected into the endometrium after hysteroscopy under the guidance of ultrasound

DRUG

Collagen/BMMNCs

A collagen scaffold loaded with BMMNCs will be transplanted into the uterine cavity after hysteroscopy under the guidance of ultrasound

DRUG

Estrogen

Patients will receive regular estrogen therapy

Trial Locations (1)

RECRUITING

Nanjing Drum Tower Hospital, Nanjing